agilon health to Participate in Upcoming Investor Conferences

LONG BEACH, Calif.--(BUSINESS WIRE)-- agilon health, inc. (NYSE: AGL), the company transforming health care for seniors by empowering primary-care physicians to focus on the entire health of their patients, announced that it will participate in the following upcoming investor conferences:

• The William Blair 41st Annual Growth Stock Conference, including a presentation on Thursday, June 3 at 3:40-4:10 PM Eastern Time.
• The Goldman Sachs 42nd Annual Global Healthcare Conference, including a presentation on Tuesday, June 8 at 2:10-2:50 PM Eastern Time.

Interested investors and other parties may listen to a simultaneous webcast of each event by visiting the “Events & Presentations” section of https://investors.agilonhealth.com. Replays will be available for on-demand listening shortly after the completion of each presentation.

About agilon health

agilon health is transforming health care for seniors by empowering primary-care physicians to focus on the entire health of their patients. Through our partnerships and our platform, agilon is leading the nation in creating the system we need – one built on the value of care, not the volume of fees. We honor the independence of local physicians and serve as their partners so they can be the doctors they trained to be. agilon provides the capital, data, payor relationships, executive experience and contract support that allow physician groups to take on the risk of total care for their most vulnerable patients. The result: healthier communities, and doctors who can devote the right amount of time with the patients who need it most. With rapidly growing appeal, agilon is scaled to grow and is here to help our nation’s best independent physician groups have a sustained, thriving future. Together, we are reinventing primary care.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210601005746/en/

Investor Contact
Matthew Gillmor
VP of Investor Relations
[email protected]

Media Contact
Shannan Siemens
Managing Director, Mercury
[email protected]

Source: agilon health

You May Also Be Interested In

• Fujirebio Expands Access in Canada to Blood-based Neurology Testing with Health Canada Class II Medical Device Licenses for the Lumipulse® G NfL Blood and Lumipulse G pTau 217 Plasma Assays
• Weekly progress on share repurchase program to cover share plans and reduce capital
• Good Purpose Investments Engages Atrium Research Corporation for Equity Research Coverage